JPRN-UMIN000017204已完成3 期
Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Tea Containing Enzymatically Modified Rutin on Lipid Metabolism Improvement - The Effect of Daily Ingestion of the Tea Containing Enzymatically Modified Rutin on Lipid Metabolism Improvement
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subjects who are under treatment and medication for hyperlipidemia, diabetes and/or hypertension 2. Subjects with serious cerebrovascular, cardiac, hepatic, renal, and / or gastrointestinal diseases, or affected with an infectious disease which is required to report to the authorities 3.Subjects who have a major surgical history related to digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 4. Subjects with unusually high and/or low blood pressure or abnormal hematological data 5. Subjects with serious anemia 6. Pre- or post-menopausal subjects having complaints of obvious physical changes 7. Subjects who are at risk of having allergic reactions to drugs or foods (especially tea) 8. Subjects regularly take medicine , functional foods and/or supplements (EPA, DHA, MCT, phytosterol, sesamin, turmeric, polyphenols, and/or dietary fiber, etc.) which would affect the blood lipids. 9. Subjects regularly take medicine functional foods and/or supplements based on dietary fiber from resistant dextrin, and/or polyphenols, etc. which would affect the blood glucose. 10. Subjects regularly take medicine, functional foods and/or supplements ( peptide, acetic acid, GABA, geniposidic acid, flavonoids, sesamin, chlorella, olive leaves, garlics, dietary fiber, tomatoes, folic acid, etc.) which would affect the blood pressure. 11. Heavy smokers, alcohol addicts or subjects with irregular lifestyle 12. Subjects who donate either 400ml whole blood within 12 weeks or 200ml whole blood within 4 weeks or blood components within 2 weeks prior to this study. 13. Subjects who are pregnant or expected to be pregnant, or lactating during the study 14. Subjects who participate in other clinical trials within the last one month prior to the current clinical trial 15. Any other medical reasons judged by the the principal investigator
研究者
相似试验
已完成
3 期
Double-Blind, Placebo-Controlled Study for the Effect of Lyophilized Herring-Roe Powder on Lipid Metabolism ImprovementHealthy subjectsJPRN-UMIN000017072Hokkaido Information University32
已完成
不适用
Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of Yabukita green tea and Sun Rouge green tea on the Improvement of Blood Pressure and EyestraiJPRN-UMIN000018469Hokkaido Information University108
已完成
3 期
Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Plum Extract on the Improvement of Blood Pressure and Blood FlowHealthy adultsJPRN-UMIN000017917Hokkaido Information University52
已完成
3 期
Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Mulberry Leaf Tea on the improvement of Liver FunctioHealthy adultsJPRN-UMIN000017916Hokkaido Information University32
进行中（未招募）
1 期
Study comparing the effect of MIN-102 and an inactive substance to learn more about the effects of the MIN-102 on Biochemical, Imaging, Neurophysiological, and Clinical Markers in Patients with Friedreich’s Ataxia, in which neither investigators nor subjects know what treatment the subject is receiving.Friedreich’s AtaxiaMedDRA version: 20.0Level: PTClassification code 10017374Term: Friedreich's ataxiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-004405-64-ESMinoryx Therapeutics BE, SA39